Ceribell ClarityPro Receives FDA Clearance
Ceribell announced that its new software ClarityPro has received 510(k) clearance from the FDA for the indication of diagnosing ESE.
Ceribell announced that its new software ClarityPro has received 510(k) clearance from the FDA for the indication of diagnosing ESE.
Ceribell announced that its new software ClarityPro has received 510(k) clearance from the FDA for the indication of diagnosing ESE.